Cell BiologybioRxivPreprint
Metabolic reprogramming provides a novel approach to overcome resistance to BH3-mimetics in Malignant Pleural Mesothelioma
X.-M. Sun, G. J. Miles, A. Craxton…·M. MacFarlane
This study identifies metabolic reprogramming as a strategy to overcome resistance to BH3-mimetics in MPM by combining glycolytic inhibition with MCL-1 and BCL-2/BCL-XL targeting.
DOI 10.1101/2023.03.31.534530